Phase 3 Bowel Cancer Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Completed
Phase 3
Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies (TARGET-TP)
Liver CancerPancreatic CancerLung Cancer+4 more
Peter MacCallum Cancer Centre300 enrolled5 locationsACTRN12618000811202
Completed
Phase 3
The influence of initial screening test technology on participation in rescreening for colorectal cancer
Screening for bowel cancer
Prof. Graeme Young MD, FRACP1,818 enrolled1 locationACTRN12605000462684
Completed
Phase 3
The value of GP endorsement on participation in rescreening for colorectal cancer
Screening for bowel cancer
Prof. Graeme Young MD, FRACP2,400 enrolled1 locationACTRN12605000461695
Completed
Phase 3Phase 4
A preliminary safety study comparing the concentration of a local anaesthetic absorbed into the blood (when trickling near the surgical site for 96hours after surgery) to published threshold for toxicity
Bowel Cancer Surgery
TQEH Research Foundation10 enrolled1 locationACTRN12605000413628
Active
Phase 3
Interventions to improve participation in bowel cancer screening: the value of lay advocacy and positive framing of risk.
Screening for bowel cancer
Prof. Graeme Young MD, FRACP1,800 enrolled1 locationACTRN12605000279628
Active
Phase 3
The value of an advance notification letter prior to a postal offer of bowel cancer screening on population participation in screening.
Screening for bowel cancer
Prof. Graeme Young MD, FRACP1,200 enrolled1 locationACTRN12605000239662